portfolio
partnership
innovation
about us
contact
NL

Miranda Eleveld

Miranda Eleveld
Manager Quality Assurance & Regulatory Affairs

E-mail +31 6 434 312 66

homepage
innovation
portfolio
partnership
about us
contact

portfolio
oncolytica
anesthetica
antibiotics
cardiac stimulants
antihypertensives
parasympathicolytics
dopamine antagonists
proton pump inhibitors
adrenergics and dopaminergics

portfolio
diuretics
analgesics
muscle relaxants
alpha blockers
acetylcholinesterase inhibitors
antihistaminics
vitamins
blood glucose

partnership
business models
becoming partner
testimonials

about us
facts & figures
certificates
core values
stories
timeline
locations

contact
contact information
contacts
linkedin
newsletter

© Eureco-Pharma

privacy policy general terms and conditions follow us

homepage
innovation
portfolio
partnership
about us
contact

partnership
business models
becoming partner
testimonials

portfolio
oncolytica
anesthetica
antibiotics
cardiac stimulants
antihypertensives
parasympathicolytics
dopamine antagonists
proton pump inhibitors
adrenergics and dopaminergics

portfolio
diuretics
analgesics
muscle relaxants
alpha blockers
acetylcholinesterase inhibitors
antihistaminics
vitamins
blood glucose

about us
facts & figures
certificates
core values
stories
timeline
locations

contact
contact information
contacts
linkedin
newsletter

© Eureco-Pharma

privacy policy general terms and conditions follow us

homepage
innovation
portfolio
partnership
about us
contact

portfolio
oncolytica
anesthetica
antibiotics
cardiac stimulants
antihypertensives
parasympathicolytics
dopamine antagonists
proton pump inhibitors
adrenergics and dopaminergics

portfolio
diuretics
analgesics
muscle relaxants
alpha blockers
acetylcholinesterase inhibitors
antihistaminics
vitamins
blood glucose

partnership
business models
becoming partner
testimonials

about us
facts & figures
certificates
core values
stories
timeline
locations

contact
contact information
contacts
linkedin
newsletter

© Eureco-Pharma

privacy policy general terms and conditions follow us